Current status of thalassemia in minority populations in Guangxi, China

Clinical Genetics

Volumn 71, Issue 5, 2007, Pages 419-426

  Pan, H F ^a,b   Long, G F ^c   Li, Q ^b   Feng, Y N ^b   Lei, Z Y ^b   Wei, H W ^b   Huang, Y Y ^b   Huang, J H ^b   Lin, N ^b   Xu, Q Q ^b   Ling, S Y ^b   Chen, X J ^b   Huang, Taosheng ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Nephrology   (China)

^c GUANGXI MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Minority; Mutations spectrum; Prevalence; Prevention thalassemia

Indexed keywords

ALANINE; ASPARTIC ACID; BETA GLOBIN; CYSTEINE; DEFEROXAMINE; HEMOGLOBIN; THREONINE;

ADOLESCENT; AGE DISTRIBUTION; ALPHA THALASSEMIA; AMINO ACID SUBSTITUTION; ARTICLE; BETA THALASSEMIA; BIOASSAY; BLOOD ANALYSIS; BLOOD TRANSFUSION; CHINA; CODON; CONTROLLED STUDY; DISEASE CONTROL; FETUS; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; HEALTH EDUCATION; HETEROZYGOTE DETECTION; HUMAN; MAJOR CLINICAL STUDY; MINORITY GROUP; MORTALITY; NEWBORN; PRIORITY JOURNAL; PUBLIC HEALTH; SCHOOL CHILD; SPRING;

ADOLESCENT; CHILD; CHINA; FEMALE; HUMANS; MALE; MINORITY GROUPS; MODELS, GENETIC; MUTATION; PREGNANCY; PRENATAL DIAGNOSIS; PREVALENCE; THALASSEMIA;

EID: 34248389357     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2007.00791.x     Document Type: Article

References (38)

1. Weatherall DJ. Thalassaemia: The long road from bedside to genome. Nat Rev Genet 2004: 5 (8): 625-631.
2. Weatherall DJ. Genomics and global health: Time for a reappraisal. Science 2003: 302 (5645): 597-599.
3. Weatherall DJ. Keynote address: The challenge of thalassemia for the developing countries. Ann N Y Acad Sci 2005: 1054: 11-17.
4. Weatherall D. 2003 William Allan Award address. The Thalassemias: The role of molecular genetics in an evolving global health problem. Am J Hum Genet 2004: 74 (3): 385-392.
5. Alwan A, Modell B. Recommendations for introducing genetics services in developing countries. Nat Rev Genet 2003: 4 (1): 61-68.
6. Modell B, Khan M, Darlison M, et al. A national register for surveillance of inherited disorders: Beta thalassaemia in the United Kingdom. Bull World Health Organ 2001: 79 (11): 1006-1013.
7. Lau YL, Chan LC, Chan YY et al. Prevalence and genotypes of alpha- and beta-thalassemia carriers in Hong Kong -implications for population screening. N Engl J Med 1 1997: 336 (18): 1298-1301.
8. Kan YW, Allen A, Lowenstein L. Hydrops fetalis with alpha thalassemia. N Engl J Med 5 1967: 276 (1): 18-23.
9. Kan YW.MThe William Allan Memorial Award address: Thalassemia: molecular mechanism and detection. Am J Hum Genet 1986: 38 (1): 4-12.
10. Lin TM, Eng HL, Kuo PL, Wu HL. Neonatal screening for alpha-thalassemia in southern Taiwan. J Formos Med Assoc 1992: 91 (12): 1213-1215.
11. Zhang BH. A survey of HbBart's content in cord blood in Nanning area of Guangxi province and genotypes of α-thalassemia. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1986: 8 (3): 185-189.
12. Zhao W. The relationship between HbBart's content in cord blood and the deletions of thalassemia. Chin J Hematol 1988: 9 (11): 649-657.
13. Fei YJ, Kutlar F, Harris HF 2nd et al. A search for anomalies in the zeta, alpha, beta, and gamma globin gene arrangements in normal black, Italian, Turkish, and Spanish newborns. Hemoglobin 1989: 13 (1): 45-65.
14. Tang ZN, Liang X, Liang R. Detection of the ζ chain for diagnosis of α-thalassemia 1 by PAGE. Chin J Hematol 1988 9: 687-688.
15. Cao A. Carrier screening and genetic counselling in beta-thalassemia. Int J Hematol 2002: 76 (Suppl. 2): 105-113.
16. Liao C, Mo QH, Li J et al. Carrier screening for alpha- and beta-thalassemia in pregnancy: The results of an 11-year prospective program in Guangzhou Maternal and Neonatal hospital. Prenat Diagn 2005: 25 (2): 163-171.
17. Old J, Petrou M, Varnavides L, Layton M, Modell B. Accuracy of prenatal diagnosis for haemoglobin disorders in the UK: 25 years' experience. Prenat Diagn 2000: 20 (12): 986-991.
18. Cao A, Rosatelli MC, Monni G, Galanello R. Screening for thalassemia: A model of success. Obstet Gynecol Clin North Am 2002: 29 (2): 305-328, vi-vii.
19. Zhou Y, Zhang Y, Li L et al. [Rapid detection of three common deletional alpha thalassemias in Chinese by single-tube multiplex PCR]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2005: 22 (2): 180-184.
20. Bang-Ce Y, Hongqiong L, Zhuanfong Z, Zhengsong L, Jianling G. Simultaneous detection of alpha-thalassemia and beta-thalassemia by oligonucleotide microarray. Haematologica 2004: 89 (8): 1010-1012.
21. Chen P, Long GF, Lin WX, Li SQ. [Homozygous hemoglobin constant spring in Guangxi province]. Zhonghua Xue Ye Xue Za Zhi 2004: 25 (4): 205-208.
22. Armeli C, Robbins SJ, Eunpu D. Comparing knowledge of beta-thalassemia in samples of Italians, Italian-Americans, and non-Italian-Americans. J Genet Couns 2005: 14 (5): 365-376.
23. Clark BE, Thein SL. Molecular diagnosis of haemoglobin disorders. Clin Lab Haematol 2004: 26 (3): 159-176.
24. Sirichotiyakul S, Tantipalakorn C, Sanguansermsri T, Wanapirak C, Tongsong T. Erythrocyte osmotic fragility test for screening of alpha-thalassemia-1 and beta-thalassemia trait in pregnancy. Int J Gynaecol Obstet 2004: 86 (3): 347-350.
25. Xu XM, Zhou YQ, Luo GX et al. The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: Implications for the future health burden and population screening. J Clin Pathol 2004: 57 (5): 517-522.
26. Thong MK, Soo TL. The spectrum of beta-globin gene mutations in children with beta-thalassaemia major from Kota Kinabalu, Sabah, Malaysia. Singapore Med J 2005: 46 (7): 340-343.
27. Svasti ML, Hieu TM, Munkongdee T et al. Molecular analysis of beta-thalassemia in South Vietnam. Am J Hematol 2002: 71 (2): 85-88.
28. Liu JZ, Ou CY, Wang LR, Xiao B, Huang LJ, Chen LC. Detection of three common, deletional alpha-thalassemia determinants in Southern China by a single-tube multiplex polymerase chain reaction method. Hemoglobin 2004: 28 (1): 39-44.
29. [Survey on hemoglobinopathy among 600,000 residents of 20 provinces, cities and autonomous regions of China]. Zhonghua Yi Xue Za Zhi 1983: 63 (6): 382-385.
30. Kham SK, Quah TC, Loong AM et al. A molecular epidemiologic study of thalassemia using newborns' cord blood in a multiracial Asian population in Singapore: Results and recommendations for a population screening program. J Pediatr Hematol Oncol 2004: 26 (12): 817-819.
31. Chern JP, Lin KH, Su YN et al. Impact of a national beta-thalassemia carrier screening program on the birth rate of thalassemia major. Pediatr Blood Cancer 2006: 46 (1): 72-76.
32. Cai R, Li L, Liang X et al. [Prevalence survey and molecular characterization of alpha and beta thalassemia in Liuzhou city of Guangxi]. Zhonghua Liu Xing Bing Xue Za Zhi 2002: 23 (4): 281-285.
33. Sadelain M, Lisowski L, Samakoglu S, Rivella S, May C, Riviere I. Progress toward the genetic treatment of the {beta}-Thalassemias. Ann N Y Acad Sci 2005: 1054: 78-91.
34. Schrier SL, Angelucci E. New strategies in the treatment of the thalassemias. Annu Rev Med 2005: 56: 157-171.
35. Kan YW. Yuet Wai Kan, MD: Sickle cell and thalassemia pioneer. Interview by Tracy Hampton. JAMA 1 2006: 295 (9): 991.
36. Karnon J, Zeuner D, Brown J, Ades AE, Wonke B, Modell B. Lifetime treatment costs of beta-thalassaemia major. Clin Lab Haematol 1999: 21 (6): 377-385.
37. Ahmed S, Saleem M, Modell B, Petrou M. Screening extended families for genetic hemoglobin disorders in Pakistan. N Engl J Med 10 2002: 347 (15): 1162-1168.
38. Harris R, Lane B, Harris H et al. National Confidential Enquiry into counselling for genetic disorders by non-geneticists: General recommendations and specific standards for improving care. Br J Obstet Gynaecol 1999: 106 (7): 658-663.